5%咪喹莫特乳膏成功治疗角化棘皮瘤和光化性角化病。 - Suppr | 超能文献

Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream.

作者信息

Peris Ketty, Micantonio Tamara, Fargnoli Maria Concetta

出版信息

Eur J Dermatol. 2003 Jul-Aug;13(4):413-4; author reply 415.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream.5%咪喹莫特乳膏成功治疗角化棘皮瘤和光化性角化病。

Eur J Dermatol. 2003 Jul-Aug;13(4):413-4; author reply 415.

2

Topical treatment with imiquimod may induce regression of facial keratoacanthoma.用咪喹莫特进行局部治疗可能会促使面部角化棘皮瘤消退。

Eur J Dermatol. 2003 Jan-Feb;13(1):80-2.

3

Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.5%氟尿嘧啶乳膏与5%咪喹莫特乳膏治疗面部和头皮光化性角化病的比较。

J Drugs Dermatol. 2007 Feb;6(2):144-7.

4

Successful treatment of keratoacanthoma centrifugum marginatum with local application of imiquimod cream.咪喹莫特乳膏局部应用成功治疗离心性边缘性角化棘皮瘤。

Int J Dermatol. 2007 Dec;46(12):1321-2. doi: 10.1111/j.1365-4632.2007.03397.x.

5

Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris.咪喹莫特作为寻常狼疮背景下发生的巨大角化棘皮瘤的新辅助治疗。

Clin Exp Dermatol. 2014 Jan;39(1):60-2. doi: 10.1111/ced.12184. Epub 2013 Jun 18.

6

Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.车辆对照、双盲、随机研究，每周3天应用5%咪喹莫特乳膏，分一或两个疗程治疗头部光化性角化病。

J Am Acad Dermatol. 2007 Aug;57(2):265-8. doi: 10.1016/j.jaad.2007.01.047. Epub 2007 May 18.

7

A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck.一项双盲、赋形剂对照研究，评估马索罗酚乳膏对头颈部光化性角化病的治疗效果。

J Am Acad Dermatol. 1991 May;24(5 Pt 1):738-43. doi: 10.1016/0190-9622(91)70113-g.

8

Imiquimod cream in the treatment of actinic keratoses.咪喹莫特乳膏治疗光化性角化病。

J Am Acad Dermatol. 2002 Oct;47(4 Suppl):S236-9. doi: 10.1067/mjd.2002.126581.

9

Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.5%咪喹莫特乳膏治疗面部、头皮、手部及手臂光化性角化病的药代动力学及安全性

Arch Dermatol Res. 2004 Jun;296(1):6-11. doi: 10.1007/s00403-004-0465-4. Epub 2004 Apr 9.

10

Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study.维甲酸甲酯砜（Ro 14 - 9706）乳膏与维甲酸乳膏对面部多发性光化性角化病的局部治疗：一项双盲对照研究。

J Am Acad Dermatol. 1991 Mar;24(3):448-51. doi: 10.1016/0190-9622(91)70070-i.

引用本文的文献

1

Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.蕈样肉芽肿综合征患者自然杀伤细胞中差异表达的Toll样受体信号基因概况。

Oncotarget. 2017 Sep 18;8(54):92183-92194. doi: 10.18632/oncotarget.21006. eCollection 2017 Nov 3.